LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 5698 | 11155 | 0.5108 | 0.4232 |
MCF 10A | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10046 | 11155 | 0.9006 | 0.8828 |
MCF 10A | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 8613 | 11155 | 0.7721 | 0.7313 |
MCF 10A | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10792 | 11155 | 0.9674 | 0.9616 |
MCF 10A | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 3384 | 11155 | 0.3034 | 0.1786 |
MCF 10A | PI103 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11398 | 11155 | 1.0218 | 1.0257 |
MCF 10A | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 11028 | 11155 | 0.9886 | 0.9865 |
MCF 10A | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 12035 | 11155 | 1.0789 | 1.0930 |
MCF 10A | QL-XII-47 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10935 | 11155 | 0.9802 | 0.9767 |
MCF 10A | Radicicol | 0.12 | uM | LJP5 | 72 | hr | 1694 | 7622 | 11155 | 0.6833 | 0.6266 |
MCF 10A | Radicicol | 0.12 | uM | LJP6 | 72 | hr | 1694 | 7232 | 11155 | 0.6483 | 0.5853 |
MCF 10A | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10898 | 11155 | 0.9769 | 0.9728 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 11068 | 11155 | 0.9922 | 0.9908 |
MCF 10A | XL147 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10818 | 11155 | 0.9697 | 0.9643 |
MCF 10A | Saracatinib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10704 | 11155 | 0.9595 | 0.9523 |
MCF 10A | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 4842 | 11155 | 0.4341 | 0.3327 |
MCF 10A | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 1694 | 12338 | 11155 | 1.1060 | 1.1250 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 11824 | 11155 | 1.0600 | 1.0707 |
MCF 10A | SU11274 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10937 | 11155 | 0.9804 | 0.9769 |
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10674 | 11155 | 0.9568 | 0.9491 |
MCF 10A | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10876 | 11155 | 0.9750 | 0.9705 |
MCF 10A | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 3778 | 11155 | 0.3387 | 0.2203 |
MCF 10A | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 1694 | 2733 | 11155 | 0.2450 | 0.1098 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 2001 | 11155 | 0.1794 | 0.0324 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 2983 | 11155 | 0.2675 | 0.1363 |